BETTER SCIENCE. BETTER DESIGN.
Anteris’ DurAVR™ THV 3D single-piece, native-shaped valve delivers superior performance with the promise of durability – its innovative design is engineered to last the remainder of a patient’s lifetime. The proven benefits of its patented ADAPT® tissue technology, paired with the unique single-piece, native valve shape, valuably positions DurAVR™ valve to deliver a game-changing treatment for patients worldwide with aortic stenosis - providing a needed solution to the challenges physicians are facing today with their patients.
ADVANCING TISSUE SCIENCE FOR PERFORMANCE AND DURABILITY
DurAVRTM 3D single-piece, shaped valve is designed like the native aortic valve
- Larger EOA
- More consistent laminar flow
- Improved exercise capacity
ADAPT® Anti-calcification Process 1
- Proprietary tissue processing designed to neutralize bovine pericardium tissue to resist calcification
- Clinical durability with no calcification in over 10 years
ComASUR™ Delivery System
BUILT FOR PREDICTABILITY
- Predictable, familiar, steerable balloon expandable delivery and deployment
- Rotational control for commissural alignment and optimized coronary access
REFERENCES
[1] Neethling W, Rea A, Forster G and Bhirangi K (2020) Performance of the ADAPT-Treated CardioCel® Scaffold in Pediatric Patients With Congenital Cardiac Anomalies: Medium to Long-Term Outcomes. Front. Pediatr. 8:198. doi: 10.3389/fped.2020.00198Neethling W, Rea A, Forster G and Bhirangi K (2020) Performance of the ADAPT-Treated CardioCel® Scaffold in Pediatric Patients With Congenital Cardiac Anomalies: Medium to Long-Term Outcomes. Front. Pediatr. 8:198. doi: 10.3389/fped.2020.00198
LATEST ANTERIS NEWS
Subscribe